dichlororibofuranosylbenzimidazole has been researched along with Teratocarcinoma in 1 studies
Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
Teratocarcinoma: A malignant neoplasm consisting of elements of teratoma with those of embryonal carcinoma or choriocarcinoma, or both. It occurs most often in the testis. (Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Langley, RE | 1 |
| Palayoor, ST | 1 |
| Coleman, CN | 1 |
| Bump, EA | 1 |
1 other study available for dichlororibofuranosylbenzimidazole and Teratocarcinoma
| Article | Year |
|---|---|
Radiation-induced apoptosis in F9 teratocarcinoma cells.
Topics: Animals; Apoptosis; Cell Differentiation; Cycloheximide; Dichlororibofuranosylbenzimidazole; DNA Dam | 1994 |